Joint Statement to the Food and Drug Administration’s Blood Product Advisory Committee – Strategies to Control the Risk of Bacterial Contamination in Platelets for Transfusion

The AABB, America’s Blood Centers (ABC) and the American Red Cross (ARC) appreciate the opportunity to present this joint statement as the Food and Drug Administration (FDA) finalizes recommendations for bacterial risk control strategies for platelet transfusion.